How could BREXIT impact the NHS?
The United Kingdom’s withdrawal from the European Union, commonly known as Brexit, has raised concerns about the potential impact on
Read moreresearch
WIRED Health 2018: Promising medical startups and innovative ideas in healthcare
WIRED Health is an annual event, held at the Francis Crick institute next to St Pancras station. This year they
Read moreThe end of the Prozac era: why pharma is abandoning psychiatry
A short history of psychiatry in the West The 1950s was a revolutionary era for the clinical introduction of new
Read moreFrom bench to bedside: Difficulties in spinal cord injury clinical trials
In developing new treatments for any disease or disorder, translating lab results to clinical benefits is a major challenge. The
Read moreAgeing as a therapeutic target
Ageing is one of the biggest causes of human suffering. It results in a functional decline in almost every organ
Read moreNeurodegenerative disease and its burden on society
The UK has an ageing population and with longer life expectancies more of us will suffer from neurodegenerative diseases. These
Read moreYour weekly BMJ digest – 29/4/17
So to do these summaries I go to my hospital library and use their copy of the BMJ (there’s less
Read moreThe road to research in non-traumatic spinal cord injury
Think of the spinal cord as a busy motorway, and cars as the electrical signals travelling from distant sites to
Read moreYour weekly BMJ digest – 22/4/17
It’s that time of the week again, folks. I know, I know, you’re all clamouring for the latest from the
Read moreMPTP a neurotoxin research model of Parkinson’s Disease
The toxin 1-methyl-4-phyenyl-1,2,3,6-tetrahydropyridine (MPTP), causes irreversible Parkinson’s disease symptoms (Parkinsonism) through the destruction of dopaminergic neurons in the substantia nigra
Read more
